Akums Drugs and Pharmaceuticals IPO vs Emcure Pharma IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Emcure Pharma IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Akums Drugs and Pharmaceuticals IPO	Emcure Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

	Akums Drugs and Pharmaceuticals IPO	Emcure Pharma IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹646.00 per share	₹960.00 per share
Issue Price (Upper)	₹679.00 per share	₹1,008.00 per share
Issue Price (Final)	₹679.00 per share	₹1,008.00 per share
Discount (Retail)
Discount (Employee)	₹64.00 per share	₹90.00 per share
Market Lot Size	22 shares	14 shares
Fresh Issue Size	1,00,14,727 shares	79,36,507 shares
Fresh Issue Size (Amount)	up to ₹680.00 Cr	up to ₹800.00 Cr
OFS Issue Size	1,73,30,435 shares	1,14,28,839 shares
OFS Issue Size (Amount)	up to ₹1,176.74 Cr	up to ₹1,152.03 Cr
Issue Size Total	2,73,45,162 shares	1,93,65,346 shares
Issue Size Total (Amount)	up to ₹1,856.74 Cr	up to ₹1,952.03 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Emcure Pharma IPO is Aug 01, 2024, and Jul 05, 2024, respectively.

	Akums Drugs and Pharmaceuticals IPO	Emcure Pharma IPO
Anchor Bid Date	Jul 29, 2024	Jul 02, 2024
Issue Open	Jul 30, 2024	Jul 03, 2024
Issue Close	Aug 01, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Aug 02, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Aug 05, 2024	Jul 09, 2024
Credit of Share (Tentative)	Aug 05, 2024	Jul 09, 2024
Listing date (Tentative)	Aug 06, 2024	Jul 10, 2024
Anchor Lockin End date 1	Sep 01, 2024	Aug 07, 2024
Anchor Lockin End date 2	Oct 31, 2024	Oct 06, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Emcure Pharma IPO P/E ratio of 34.55.

Akums Drugs and Pharmaceuticals IPO

Emcure Pharma IPO

Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,516.37	3,266.53	3,069.05
Revenue	4,212.21	3,700.93	3,694.52
Profit After Tax	0.79	97.82	-250.87
Net Worth	709.50	717.19	621.98
Reserves and Surplus	861.01	868.70	787.79
Total Borrowing	491.56	536.97	357.95
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

84.94%

98.90%

Promoter Shareholding (Post-Issue)

78.24%

P/E Ratio

34.55

Market Cap

₹19029.89 Cr.

ROE

0.11%%

16.90%%

ROCE

3.37%%

19.37%%

Debt/Equity

0.69

0.67

EPS

₹29.17

RoNW

-0.57%

16.87%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Emcure Pharma IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 38,53,234 shares in Emcure Pharma IPO.

	Akums Drugs and Pharmaceuticals IPO	Emcure Pharma IPO
Anchor Investor Reserveration	1,22,05,912 shares	57,79,850 shares
Market Maker Reserveration
QIB	81,37,276 shares	38,53,234 shares
NII	40,68,637 shares	28,89,926 shares
RII	27,12,424 shares	67,43,160 shares
Employee	2,43,902 shares	1,08,900 shares
Others
Total	1,51,62,239 shares	1,37,03,538 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Emcure Pharma IPO subscribed 67.87x.

	Akums Drugs and Pharmaceuticals IPO	Emcure Pharma IPO
QIB (times)	90.09x	191.24x
NII (times)	42.10x	49.32x
Big NII (times)	47.43x	54.90x
Small NII (times)	31.45x	38.16x
RII (times)	20.80x	7.36x
Employee (times)	4.14x	8.81x
Other (times)
Total (times)	63.44x	67.87x

Compare with others

Akums Drugs and Pharmaceuticals IPO	Emcure Pharma IPO
Interarch Building Products IPO	Brainbees Solutions (Firstcry) IPO
Orient Technologies IPO	Ceigall India IPO
Unicommerce eSolutions IPO	Akums Drugs and Pharmaceuticals IPO
Brainbees Solutions (Firstcry) IPO	Sanstar IPO
Ceigall India IPO	Bansal Wire IPO
Sanstar IPO	OLA Electric IPO
Bansal Wire IPO	Vraj Iron and Steel IPO
Emcure Pharma IPO	Aasaan Loans IPO
OLA Electric IPO	Stanley Lifestyles IPO
Vraj Iron and Steel IPO	DEE Piping Systems IPO

Comments

Add a public comment...